Pricing and Patents of HIV/AIDS Drugs in Developing Countries

Abstract: This paper provides empirical evidence on the impact of patents on drug prices across developing countries. It uses sales data on HIV/AIDS drugs in a sample of 34 low and middle-income countries between 1995 and mid-2000. The main findings are that patents do shift drug prices up, that drug prices are correlated to per capita income levels, and that drug firms follow a skimming strategy when pricing new HIV/AIDS drugs. That is, there is across country and intertemporal price discrimination in the global drug markets

Object Details

• Location: Deutsche Nationalbibliothek Frankfurt am Main
• Extent: Online-Ressource
• Language: Englisch
• Notes: Postprint ; begutachtet (peer reviewed) ; In: Applied Economics ; 39 (2007) 4 ; 505-518

Classification and Topics

• Classification: Wirtschaft

Contributors, Places and Time

• Event: Veröffentlichung
• (where): Mannheim
• (when): 2007
• Creator: Borrell, Joan-Ramon

Further information

• DOI: 10.1080/00036840500438954
• URN: urn:nbn:de:0168-ssoar-239489
• Rights: Open Access unbekannt; Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
• Last update: 25.03.2025, 1:47 PM CET